Physician profile
Patrick Kerry Denton
NPI 1851391932
$21,165.72
in general payments reported to CMS, 2019-2025
13 companies · $1,249 in 2025
The $1,249 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,100 · 2020: $2,675 · 2021: $3,811 · 2022: $1,879 · 2023: $2,306 · 2024: $4,147 · 2025: $1,249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,149 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Food and Beverage: $2,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,148.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Food and Beverage | $2,052.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $11,992.80 | 2019-2025 | |
| Peerless Surgical INC. | $7,620.02 | 2019-2025 | |
| Smith+Nephew, INC. | $653.33 | 2021-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Ultrabutton, Novostitch |
| Zimmer Biomet Holdings, INC. | $349.79 | 2019-2023 | Rosa |
| Pacira Pharmaceuticals Incorporated | $172.41 | 2019-2023 | Exparel, Zilretta, Iovera |
| Heron Therapeutics, INC. | $122.59 | 2022-2023 | Zynrelef |
| Depuy Synthes Sales INC. | $118.32 | 2022-2025 | Orthovisc, Monovisc |
| Vericel Corporation | $38.22 | 2019 | |
| Sanofi-Aventis U.S. LLC | $31.83 | 2019-2023 | |
| Horizon Therapeutics Plc | $25.25 | 2019 | |
| Bioventus LLC | $17.35 | 2019 | |
| Convatec INC. | $11.95 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Denton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.